Skip to content

Red Flags for Cardiac Examination for Early Detection of Congenital Heart Disease

The Relation Between the Presence of Abnormal Clinical Cardiac Findings and Echocardiographic Findings in Newborn Infants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04801251
Enrollment
70
Registered
2021-03-16
Start date
2021-10-20
Completion date
2022-12-20
Last updated
2021-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

The study done to identify the relation between the presence of abnormal clinical cardiac findings and the echocardiographic findings in newborn infants.

Detailed description

A full history will be taken, complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination.

Interventions

Each patient included will undergo full cardiac physical examination and echocardiographic examination

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

The relation between the presence of abnormal clinical cardiac findings and the abnormal echocardiographic findings

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* • Abnormal heart rate (\< 90/min or \< 160 per min ) * Comfortable tachypnea ( RR \> 60/min without other manifestations of respiratory distress) * Abnormal heart sounds (muffled, accentuated, single ) * Abnormal precordial activity * Murmur: ( ≥ grade 3 intenisty, holosystolic timing, maximum intensity at upper left sternal border or with upright positing, diastolic murmur, harsh or blowing quality ) * Abnormal oxygen saturation \<90% in any extremity Oxygen saturation gradient \> 3% difference in extremities. * Blood pressure gradient \>10 mmHg higher in arms \>10 mmHg lower in legs * Abnormal femoral pulses * Weakened pulses * Absent pulses * Hepatomegaly * Family history of cardiac disease

Exclusion criteria

* Newborns with disorders affecting the heart as anemia, septicemia, respiratory disorders as respiratory distress syndrome, pneumonia, hypoplastic lung, renal impairment, hypertension, metabolic disease, syndromatic CHF

Design outcomes

Primary

MeasureTime frameDescription
Red flags for cardiac examination1 yearA complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination. Methods: 1. Echocardiogram reports will be reviewed and cardiovascular abnormalities will be noted. The presence of patent ductus arteriosus (PDA) will be considered a normal finding if present at ≤ 7 days of age but not beyond. A patent foramen ovale will be considered normal. A small muscular ventricular septal defect (VSD), although common in neonates and, will be considered an abnormal finding. 2. All patients will have pulse oximeter screening, newborns with pulse oximetry ≥ 95% in the right hand or foot and ≤ 3% difference between the right hand and either foot at any time of testing have a normal result, and require no further testing.
The importance of history in detecting congenital heart disease1 yearA full history will be taken, family history of congenital heart disease, mother's age and consanguinity, gravidity and parity should also be included. A File will be prepared for each neonate, which consist of demographic details including cardiac physical examination findings, birth weight, fetal age, history of folic acid intake by the mother, family history of cardiac disease, pulse oximeter screening, and results will be recorded. Data will be collected in form of taking history by interviewing questionnaire and full clinical examination will be done particularly cardiac examination and all findings will be recorded in patient clinical checklist. X\^2 will be used to compare frequencies among different categories. Student T test, ANOVA will be used to test differences between means. ALL statistical analysis will be performed by using the SPSS version 20. P value \<0.05 will be considered statistically significant for all applied statistical tests.

Contacts

Primary ContactSarah Bakry, Resident
Sarabakry94@gmail.com01129324744
Backup ContactAmira Shalaby, Lecturer
amirashalaby@aun.edu.eg01223958949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026